One year. Five new products. 2017 marked another record year for new product launches at Stratedigm. And CellCapTure 4.1—our flow cytometry acquisition and analysis software—is the foundation of Stratedigm’s latest innovations. Never before have such revolutionary products like the patent pending Visual Protocol Designer (VPD), Universal-API for automation, IoT empowered Control Center, and the A800 Cell Incubator (CI) been seamlessly integrated in […]

Madison, WI – Cellular Dynamics International (CDI), a FUJIFILM company, the leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSC-cells, announced that its iCell® Cardiomyocytes were launched into space via SpaceX’s 13th commercial resupply services mission to the International Space Station on Dec.15, 2017. The purpose of the scientific research […]

Signs Master Collaboration Agreement for Assay Development and Manufacturing of Kits Supporting Biomarker Research Programs TUCSON, Ariz. and DARMSTADT, Germany — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications today announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany, a leading science and technology company. The Master Collaboration Agreement […]

Helsinki – MediSapiens, a leading developer and provider of genomic, biomedical and healthcare data solutions, joins the recently announced 59M€ FinnGen project, that aims at improving human health through genetically profiling 500.000 Finns, and combining that with a rich set of clinical data to identify new therapeutic targets, as well as diagnostic and prognostic markers […]

Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announces that, mainly as a consequence of the new U.S. tax legislation, it will take an after-tax charge on net income of approximately $110-120 million (or about $0.47-$0.52 per share) in the fourth quarter of 2017, and an additional after-tax charge in […]

NDF and PerkinElmer to collaborate on a deeper look at GNE Myopathy BEVERLY HILLS, Calif. The Neuromuscular Disease Foundation (NDF) – the world’s leading nonprofit organization focused on the rare genetic disease called GNE Myopathy (GNEM, also known as HIBM) is pleased to announce its collaboration with PerkinElmer for Whole Genome Sequencing (WGS) paired with […]

NGS platform to generate additional clinical data to build out the Skyline-Helomics D-CHIP bioinformatics platform MINNEAPOLIS — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that it is expanding into Next Generation Sequencing (“NGS”) through the licensing of an NGS platform MiSeqDx®, from Illumina. […]

ArcticZymes today announced the expansion of their polymerase portfolio. The IsoPol™ SD⁺ and IsoPol™ BST⁺ deliver low temperature isothermal polymerases, one with increased strand displacement, and the second an improvement over existing Bacillus stearothermophilus available today. IsoPol™ SD+ is a DNA polymerase with stronger strand displacement activity, and higher salt tolerance compared to ArcticZymes first […]

— Aims to accelerate manufacturing of new treatments for broad range of serious diseases — Underscores MilliporeSigma as a leading contract manufacturing organization and commercial provider of viral vectors for gene therapy BURLINGTON, Mass. — MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, for […]

WALTHAM, Mass. — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 […]